Frailty Clinical Trial - Evaluation of a Frailty Intervention Program in

Status Completed

Clinical Trial Summary

The present study aims to compare the pre-post effect of a frailty intervention program with exercise, nutrition, cognitive and social components with a control group without such program on improving gait speed and frailty in community-dwelling Chinese adults aged 50 and above who are pre-frail or frail using the FRAIL scale, and to obtain their views towards the frailty intervention program. The investigators hypothesized that the frailty intervention program will result in improvements regarding frailty, mobility, weight status and other health outcomes. This study will be a non-randomized controlled study using a controlled before-and-after study design. Eligible subjects will be assigned to one of the two groups: frailty intervention program, or control group without any intervention, over 12 weeks. A total of 152 subjects (76 per group) will be recruited. A sub-sample of 25 subjects from the intervention group will be invited to share their experience and opinion in focus groups.

Clinical Trial Description

A 30-month trial, which will be divided into three phases, namely study preparation and subject recruitment (6 months), data collection (18 months), and data entry and analysis (6 months), will be conducted. This study will be a non-randomized controlled study using a controlled before-and-after study design. Eligible subjects will receive a baseline assessment in the community facilities. After that, eligible subjects will be assigned to one of the two groups: frailty intervention program, or control group without any intervention, over 12 weeks. Subjects in the frailty intervention program will be invited to participate in the following components: exercise, game training and nutrition education; while subjects in the control group will be asked to maintain their usual diet and physical activity patterns. A total of 152 subjects (76 per group) will be recruited. Outcome measurements will be collected at two time points, namely baseline (T0), and 12 (T1) weeks. The primary outcome will be the improvement in gait speed over 12 weeks. Secondary outcomes will include the change in the following parameters over 12 weeks: frailty, handgrip strength, 5 chair stands, balance test, Frontal Assessment Battery, dietary intake, nutritional status, physical activity, self-rated health, life satisfaction and self-efficacy of chronic disease management. In a sub-sample of 25 subjects from the intervention group, their views towards the frailty intervention program will be obtained from the focus group study. ;

Study Design

Related Conditions & MeSH terms

Frailty

Clinical Trial Details

NCT number	NCT04216056
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	January 3, 2020
Completion date	May 25, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04992286` - Detection, Evaluation and Monitoring of Frailties in the Elderly (FRAGING)	N/A
Enrolling by invitation	`NCT05009706` - Self-care in Older Frail Persons With Heart Failure Intervention	N/A
Completed	`NCT05529147` - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting	`NCT04444544` - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed	`NCT04061785` - Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women	N/A
Completed	`NCT04140890` - Supporting Habit Formation to Attenuate Prefrailty in Elders: Pilot Study	N/A
Recruiting	`NCT03141866` - Seated Physical Activity in Ageing	N/A
Completed	`NCT04888884` - Loss of Independence - a Rapid Alternative to Frailty Screening in a Swedish ED Setting
Recruiting	`NCT04145726` - Frailty In Thoracic Surgery for Esophageal Cancer
Recruiting	`NCT04717869` - Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Not yet recruiting	`NCT06022666` - PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.	N/A
Not yet recruiting	`NCT04514536` - Evaluation of a Health Monitoring Platform for Elderly in Home Care Context	N/A
Completed	`NCT01126723` - Effects of Tai Chi on Frailty in Elderly Adults	N/A
Completed	`NCT00183040` - HORMA: Hormonal Regulators of Muscle and Metabolism in Aging	Phase 2
Active, not recruiting	`NCT05961319` - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Enrolling by invitation	`NCT05047731` - Antihypertensive Deprescribing in Long-term Care	N/A
Completed	`NCT04956705` - Vitamin D and Calcium Supplementation at Danish Nursing Homes	N/A
Recruiting	`NCT03824106` - Frailty Rehabilitation	Phase 4
Recruiting	`NCT04518423` - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
Completed	`NCT04087343` - Strength on Wheels: A Meal Delivery and Exercise Intervention for Homebound Older Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of a Frailty Intervention Program in Hong Kong

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms